Autosomal dominant polycystic kidney disease: symptoms and clinical findings.

Developments in the management of autosomal dominant polycystic kidney disease. Ther Clin Risk Manag (2008) 1.06

Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2012) 1.06

Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant (2011) 1.00

Adult polycystic kidney disease: knowledge, experience, and attitudes to prenatal diagnosis. J Med Genet (1990) 0.94

The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease. Hippokratia (2009) 0.86

Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant (2013) 0.80

PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease. BMC Med Genet (2006) 0.77

Association between Nephrolithiasis, Hypertension and Obesity in Polycystic Kidney Disease. Open Access Maced J Med Sci (2015) 0.75

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28

Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med (1976) 3.18

Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09

Clonal origin of human tumors. Biochim Biophys Acta (1976) 3.07

Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med (1977) 2.82

Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80

Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A (1974) 2.66

The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54

Human tumors studied with genetic markers. Birth Defects Orig Artic Ser (1976) 2.52

Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci U S A (1967) 2.48

Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38

Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A (1971) 2.26

Primordial cell pool size and lineage relationships of five human cell types. Ann Hum Genet (1973) 2.21

Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Leukemia (2007) 2.04

Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90

Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood (1978) 1.83

Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82

Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80

Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. Int J Cancer (1973) 1.80

Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79

The origin and development of human tumors studied with cell markers. N Engl J Med (1974) 1.73

A classification of tetanus. Lancet (1967) 1.72

Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67

Polyribosomes of Escherichia coli. I. Effects of monovalent cations on the distribution of polysomes, ribosomes and ribosomal subunits. J Mol Biol (1969) 1.67

Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci U S A (1992) 1.65

"Immunologic" oncogenesis. Blood (1967) 1.61

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60

Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55

Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest (1978) 1.53

Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48

Use of genetic markers to study cellular origin and development of tumors in human females. Adv Cancer Res (1972) 1.46

Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med (1973) 1.42

Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42

Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41

Autoimmunity and chromosomal aberrations. Am J Hum Genet (1966) 1.41

Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood (1981) 1.40

Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood (1981) 1.39

The pathogenesis of myeloproliferative syndromes. Br J Haematol (1978) 1.39

Presence of sarcoma genome in a "non-infectious" mammalian virus. Nat New Biol (1971) 1.39

Aplastic anaemia treated by marrow transplantation. Lancet (1972) 1.39

Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood (1984) 1.38

Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35

Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature (1982) 1.35

A new craniodigital syndrome with mental retardation. J Pediatr (1971) 1.32

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med (1987) 1.32

Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus. J Virol (1971) 1.32

Lack of association between cirrhosis and the common types of color blindness. N Engl J Med (1966) 1.29

Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int (1975) 1.29

Clonal origin for individual Burkitt tumours. Lancet (1970) 1.27

The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26

Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood (1981) 1.26

Clonal origin of human tumors. Annu Rev Med (1979) 1.25

Autoimmunity in chronic graft-versus-host disease. Clin Exp Immunol (1973) 1.23

Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med (1985) 1.22

Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20

Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20

Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis (2001) 1.17

Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17

Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1972) 1.17

Foreign-cell contamination in Burkitt tumours. Lancet (1971) 1.16

Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.16

X-chromosome inactivation and the Xg locus. Am J Hum Genet (1970) 1.15

Increased frequency of thyroid autoantibodies in mothers of patients with Down's syndrome. Lancet (1965) 1.14

Mental retardation in methemoglobinemia due to diaphorase deficiency. N Engl J Med (1965) 1.13

Anaesthesia for the surgeon-anaesthetist in difficult situations: the use of intramuscular 2(O-chlorophenyl)-2 methylamino cyclohexanone HCl (Parke Davis CI-581, Ketamine). Anaesthesia (1970) 1.13

Fine structure alterations of elastic fibers in pseudoxanthoma elasticum. Clin Genet (1978) 1.11

Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11

Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 1.11

Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol (2001) 1.11

Characterization of RNA from noninfectious virions produced by sarcoma positive-leukemia negative transformed 3T3 cells. Proc Natl Acad Sci U S A (1973) 1.11

Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow. J Cell Physiol Suppl (1982) 1.11

Autoimmunity in the relatives of patients with immunodeficiency diseases. Clin Exp Immunol (1977) 1.10

The Alström syndrome. Report of three cases with further delineation of the clinical, pathophysiological, and genetic aspects of the disorder. Medicine (Baltimore) (1973) 1.10

Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro. Blood (1979) 1.09

Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09

Unicellular or multicellular origin of human granulocyte-macrophage colonies in vitro. Blood (1979) 1.09

Multicellular origin of fibrosarcomas in mice induced by the chemical carcinogen 3-methylcholanthrene. J Exp Med (1979) 1.08

Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol (1984) 1.07

Multicellular origin of parathyroid "adenomas". N Engl J Med (1977) 1.07

Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int (1997) 1.07

A more systematic review of correlates of indoor tanning. J Eur Acad Dermatol Venereol (2011) 1.06

Multiple cell origin of hereditary neurofibromas. N Engl J Med (1971) 1.06

Cell lineages in hematopoietic neoplasia studied with glucose-6-phosphate dehydrogenase cell markers. J Cell Physiol Suppl (1982) 1.05

Chronic lymphocytic leukaemia: Clonal origin in a committed B-lymphocyte progenitor. Lancet (1978) 1.04

Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes. J Natl Cancer Inst (1976) 1.04

Genetic aspects of autoimmunity. Prog Med Genet (1969) 1.03

Measurable linkage between ocular albinism and Xg. Am J Hum Genet (1967) 1.03

Human erythroid colony formation in vitro: evidence for clonal origin. J Cell Physiol (1976) 1.03

Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol (1999) 1.02

Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2001) 1.02

Clonal origin of chronic myelocytic leukemia. N Engl J Med (1973) 1.02

Autosomal dominant polycystic kidney disease. Early diagnosis and consideration of pathogenesis. Am J Clin Pathol (1980) 1.02